药物对比
Bexagliflozin vs Glimepiride
比较 Bexagliflozin（Brenzavvy）与 Glimepiride（Amaryl）治疗2型糖尿病。SGLT2抑制剂 vs 磺脲类：疗效、副作用、体重、低血糖风险及心血管获益。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing add-on oral therapy after metformin for type 2 diabetes, particularly in patients with obesity, CVD, heart failure, CKD, or cost constraints.
结论
Bexagliflozin is generally preferred over Glimepiride for most patients due to additional cardiorenal benefits and a more favorable safety profile.
全部药物对比